MIT researchers engineered a harmless virus into a customizable platform that reduced tumor development in mice.
Tech Times on MSN
HER2-positive breast cancer trial reports 92% survival in chemo-free patients; proof pending
HER2-positive breast cancer chemotherapy can be safely omitted in about 30% of patients, five-year PHERGain trial data ...
Nanoscale particle shows potential as customizable delivery vehicle for personalized cancer vaccines
A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.
Regina McDonald's franchisees raised $10,000 for local breast and prostate cancer research through September and October promotions.
More experience, extra procedure time and a special dye were linked to finding more polyps during bowel checks for people ...
A mother whose three-year-old son must travel to the US for a vaccine trial said it has given her family a "glimmer of hope" for his future. Almost a year ago, doctors warned Tedd ...
Milestone marks the transition of BioSapien’s localized chemotherapy platform into human clinical evaluation in Abu Dhabi ...
Doctors at Montefiore Einstein Comprehensive Cancer Center are conducting an active surveillance study where certain breast ...
Dwight H. Owen, MBBCh, MS, discussed why severe immune-related toxicities remain hard to predict as immunotherapy ...
Summit Therapeutics (SMMT) has packed October with pipeline moves, including a new Phase II kidney cancer study, a Phase ...
Eau Claire resident, is taking to the pavement in honor of her best friend, Kari Hoover, who died of breast cancer in 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results